| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2006-05-22 15:12:42 UTC |
|---|
| Update Date | 2023-02-21 17:16:34 UTC |
|---|
| HMDB ID | HMDB0003224 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Deoxyribose |
|---|
| Description | Deoxyribose is an aldopentose, a monosaccharide containing five carbon atoms, and including an aldehyde functional group. It is derived from the pentose sugar ribose by the replacement of the hydroxyl group at the 2 position with hydrogen, leading to the net loss of an oxygen atom, and has chemical formula C5H10O4. In deoxyribose, the carbon furthest from the attached carbon is stripped of the oxygen atom in what would be a hydroxyl group in ribose. The common base adenine (a purine derivative) coupled to deoxyribose is called deoxyadenosine. The 5-triphosphate derivative of adenosine, commonly called adenosine triphosphate (ATP) is an important energy transport molecule in cells. -- Wikipedia . |
|---|
| Structure | OC[C@@H]1O[C@H](O)C[C@H]1O InChI=1S/C5H10O4/c6-2-4-3(7)1-5(8)9-4/h3-8H,1-2H2/t3-,4+,5+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 2'-Deoxy-D-ribose | HMDB |
|
|---|
| Chemical Formula | C5H10O4 |
|---|
| Average Molecular Weight | 134.1305 |
|---|
| Monoisotopic Molecular Weight | 134.057908808 |
|---|
| IUPAC Name | (2S,4R,5S)-5-(hydroxymethyl)oxolane-2,4-diol |
|---|
| Traditional Name | 2-deoxyribose |
|---|
| CAS Registry Number | 533-67-5 |
|---|
| SMILES | OC[C@@H]1O[C@H](O)C[C@H]1O |
|---|
| InChI Identifier | InChI=1S/C5H10O4/c6-2-4-3(7)1-5(8)9-4/h3-8H,1-2H2/t3-,4+,5+/m1/s1 |
|---|
| InChI Key | PDWIQYODPROSQH-WISUUJSJSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as pentoses. These are monosaccharides in which the carbohydrate moiety contains five carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Carbohydrates and carbohydrate conjugates |
|---|
| Direct Parent | Pentoses |
|---|
| Alternative Parents | |
|---|
| Substituents | - Pentose monosaccharide
- Tetrahydrofuran
- Secondary alcohol
- Hemiacetal
- Oxacycle
- Organoheterocyclic compound
- Hydrocarbon derivative
- Primary alcohol
- Alcohol
- Aliphatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aliphatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.02 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.7495 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.38 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 170.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 816.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 293.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 59.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 180.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 45.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 250.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 234.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 567.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 562.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 49.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 803.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 187.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 182.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 536.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 273.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 255.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Deoxyribose,1TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1O[C@H](O)C[C@H]1O | 1353.5 | Semi standard non polar | 33892256 | | Deoxyribose,1TMS,isomer #2 | C[Si](C)(C)O[C@@H]1C[C@@H](O)[C@H](CO)O1 | 1386.0 | Semi standard non polar | 33892256 | | Deoxyribose,1TMS,isomer #3 | C[Si](C)(C)O[C@@H]1C[C@@H](O)O[C@H]1CO | 1366.4 | Semi standard non polar | 33892256 | | Deoxyribose,2TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1O[C@H](O[Si](C)(C)C)C[C@H]1O | 1465.4 | Semi standard non polar | 33892256 | | Deoxyribose,2TMS,isomer #2 | C[Si](C)(C)OC[C@@H]1O[C@H](O)C[C@H]1O[Si](C)(C)C | 1446.2 | Semi standard non polar | 33892256 | | Deoxyribose,2TMS,isomer #3 | C[Si](C)(C)O[C@@H]1C[C@@H](O[Si](C)(C)C)[C@H](CO)O1 | 1443.9 | Semi standard non polar | 33892256 | | Deoxyribose,3TMS,isomer #1 | C[Si](C)(C)OC[C@@H]1O[C@H](O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C | 1513.0 | Semi standard non polar | 33892256 | | Deoxyribose,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1O[C@H](O)C[C@H]1O | 1580.0 | Semi standard non polar | 33892256 | | Deoxyribose,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@@H](O)[C@H](CO)O1 | 1588.2 | Semi standard non polar | 33892256 | | Deoxyribose,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@@H](O)O[C@H]1CO | 1590.6 | Semi standard non polar | 33892256 | | Deoxyribose,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1O[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O | 1885.0 | Semi standard non polar | 33892256 | | Deoxyribose,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@@H]1O[C@H](O)C[C@H]1O[Si](C)(C)C(C)(C)C | 1883.2 | Semi standard non polar | 33892256 | | Deoxyribose,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@@H]1C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](CO)O1 | 1879.9 | Semi standard non polar | 33892256 | | Deoxyribose,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@@H]1O[C@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C | 2168.9 | Semi standard non polar | 33892256 |
|
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
|
|
|---|
| General References | - Formichi P, Radi E, Battisti C, Tarquini E, Leonini A, Di Stefano A, Federico A: Human fibroblasts undergo oxidative stress-induced apoptosis without internucleosomal DNA fragmentation. J Cell Physiol. 2006 Aug;208(2):289-97. [PubMed:16646085 ]
- Lapenna D, Ciofani G, Festi D, Neri M, Pierdomenico SD, Giamberardino MA, Cuccurullo F: Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol. 2002 Dec 1;64(11):1661-7. [PubMed:12429355 ]
- Gutteridge JM, Quinlan GJ: Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta. 1993 Feb 13;1156(2):144-50. [PubMed:8427873 ]
- Truscott RJ, Halpern B, Hammond J, Hunt S, Cotton RG, Haan EA, Danks DM: Abnormal deoxyribose metabolites in the urine of a child with a possible new inborn error of metabolism. Biomed Mass Spectrom. 1979 Oct;6(10):453-9. [PubMed:526564 ]
- Gutteridge JM, Quinlan GJ: Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. Biochim Biophys Acta. 1992 Oct 20;1159(3):248-54. [PubMed:1327159 ]
- Chappel A, Scholem RD, Brown GK, Truscott RM, Cotton RG, Haan EA, Danks DM: Deoxyribose-5-phosphate aldolase deficiency--a harmless inborn error of metabolism. J Inherit Metab Dis. 1983;6(3):105-7. [PubMed:6422138 ]
|
|---|